Current Studies

Last updated March 5, 2024

Studies currently being conducted by the SIVS Clinical Trials Program.
For more information click on links to go to ClinicalTrials.gov, or contact (832) 340 2313, Email: sivsctp@utmb.edu.

Click here to join our registry!

Recruiting

Expand All

NCT06397768: Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (CORAL)

Sponsor: ModernaTX, Inc.
Principal Investigator: Richard Rupp, MD

For more information click here

Active, Not Recruiting

Expand All

NCT05543616: A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

Sponsor: BioNTech SE
Principal Investigator: Richard Rupp, MD

For more information click here
NCT05507450: Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)

Sponsor: Merck Sharp & Dohme LLC
Principal Investigator: Richard Rupp, MD

For more information click here
NCT05089630: A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Sponsor: GlaxoSmithKline
Principal Investigator: Richard Rupp, MD

For more information click here
NCT05087056: Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

Sponsor: GlaxoSmithKline
Principal Investigator: Richard Rupp, MD

For more information click here
NCT05085366: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Sponsor: ModernaTX, Inc.
Principal Investigator: Richard Rupp, MD

For more information click here
NCT04708041: Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Sponsor: Merck Sharp & Dohme Corp.
Principal Investigator: Richard Rupp, MD

For more information click here